Amsterdam Public Health

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors

Mfumbilwa, Z. A., Wilschut, J. A., Groen, H. J. M., Retèl, V. P., Ramaekers, B., Joore, M. & Coupé, V. M. H., Aug 2025, In: Clinical drug investigation. 45, 8, p. 583-598 16 p.

Research output: Contribution to journal › Article › Academic › peer-review

African Swine Fever Perception, Risk Factors, and Socioeconomic Disparities Among Smallholder Domestic Pig Farmers in Serengeti, Tanzania

Yona, C., Makange, M. R., Moshiro, E., Hakizimana, J. N., Mfumbilwa, Z. A., Lupala, A. S., Chengula, A. A. & Misinzo, G., 2025, In: Transboundary and Emerging Diseases. 2025, 1, 3922067.

Research output: Contribution to journal › Article › Academic › peer-review

Exploring the Cost Effectiveness of a Whole-Genome Sequencing-Based Biomarker for Treatment Selection in Patients with Advanced Lung Cancer Ineligible for Targeted Therapy

Mfumbilwa, Z. A., Simons, M. J. H. G., Ramaekers, B., Retèl, V. P., Mankor, J. M., Groen, H. J. M., Aerts, J. G. J. V., Joore, M., Wilschut, J. A. & Coupé, V. M. H., Apr 2024, In: PharmacoEconomics. 42, 4, p. 419-434 16 p.

Research output: Contribution to journal › Article › Academic › peer-review